Radnor, PA, United States of America

Peter R Paradiso

This inventor holds 20 USPTO granted patents and 1 published patent application, plus 8 CIPO patents and 4 EPO patents, primarily in Vaccine Development. Top assignees: Wyeth, Praxis Biologics, Inc., Wyeth Holdings Corporation. Active years: 1993-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter R Paradiso. Retrieved from https://idiyas.com/inventor/peter-r-paradiso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.1

ph-index = 13

Forward Citations = 437(Granted Patents)


Location History:

  • Pittsford, NY (US) (1993 - 2007)
  • Valley Forge, PA (US) (2010 - 2016)
  • Radnor, PA (US) (2016 - 2021)

Company Filing History:


Years Active: 1993-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pneumococcal Dosing Regimen
Pneumococcal Polysaccharide-Protein Conjugates
Multivalent Composition
Meningococcal Vaccine
Outer Membrane Protein
Respiratory Syncytial Virus
Vaccine Composition
Immunogenicity
20 patents (USPTO):Explore Patents

Title: The Innovations of Peter R Paradiso

Introduction

Peter R Paradiso is a notable inventor based in Radnor, PA (US), recognized for his significant contributions to the field of immunology. With a remarkable portfolio of 20 patents, Paradiso has focused on developing methods and compositions that enhance immunization against pneumococcal diseases.

Latest Patents

Among his latest patents, Paradiso has developed a pneumococcal dosing regimen aimed at immunizing older adult subjects against infections. The methods provided involve immunization of naïve adult subjects with a conjugated pneumococcal polysaccharide vaccine. This initial immunization may be followed by additional doses of either conjugated or unconjugated pneumococcal polysaccharide vaccine compositions. Another significant patent is the process for preparing pneumococcal polysaccharide-protein conjugates. This immunogenic composition includes 13 distinct polysaccharide-protein conjugates, potentially combined with an aluminum-based adjuvant. Each conjugate is derived from a different serotype, enhancing global coverage against pneumococcal disease in infants and young children.

Career Highlights

Throughout his career, Paradiso has worked with prominent companies such as Wyeth and Praxis Biologics, Inc. His work has significantly impacted the development of vaccines and immunological treatments, showcasing his dedication to public health.

Collaborations

Paradiso has collaborated with esteemed colleagues, including William P Hausdorff and George Rainer Siber. These partnerships have furthered research and innovation in the field of immunology.

Conclusion

Peter R Paradiso's contributions to immunology through his patents and collaborations highlight his commitment to advancing public health. His innovative approaches to vaccine development continue to make a significant impact in the fight against pneumococcal diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…